UPDATED – 2022 Safety Protocols

CHI has instituted mandatory health and safety protocols for all in-person participants. We are excited to bring our community back together in 2022, with trust and safety as our top priorities. All in-person participants are required to:

  • Provide proof of full vaccination against COVID-19. You will be asked to present your vaccination card (or a photo of it) at registration.
  • Have a negative COVID-19 test result from an FDA-authorized over-the-counter antigen test within 24 hours prior to arriving at the event. You will be asked your results at registration.

OPT Congress 2022 Now On-Demand

Missed this year’s event? Register for On-Demand and at your convenience, access all the content from this year’s program from anywhere at any time for up to one year.

Conference Programs

Add Dates to Outlook

Oligonucleotide Discovery and Delivery

Oligoncucleotide CMC and Regulatory Strategies

Short Courses
Event Highlights

Keynote Speakers Include:

Isabel Aznarez, PhD

Isabel Aznarez, PhD
Co-Founder, Vice President & Head, Biology, Stoke Therapeutics

Richard Geary, PhD

Richard Geary, PhD
Chief Development Officer and Executive Vice President, Antisense Drug Development, Ionis Pharmaceuticals, Inc.

Arthur M. Krieg

Arthur M. Krieg
Founder & CSO, Checkmate Pharmaceuticals

Arthur Levin, PhD

Arthur Levin, PhD
CSO, Avidity Biosciences

Michael Segel, PhD

Michael Segel, PhD
Postdoctoral Fellow, Laboratory of Dr. Feng Zhang, Broad Institute of MIT and Harvard

Our Executive Advisory Board

Dmitry Samarsky, PhD
CTO, Sirnaomics

Muthiah (Mano) Manoharan, PhD
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals

Arthur Levin, PhD
CSO, Avidity Biosciences

Lubo Nechev, PhD
Vice President Process and Analytical Sciences, Alnylam Pharmaceuticals

Ekkehard Leberer, PhD
Senior Life Sciences Consultant, ELBIOCON


Email us at:


Ready to Register?

Secure your space now